2000
DOI: 10.1006/exmp.2000.2323
|View full text |Cite
|
Sign up to set email alerts
|

Immunohistochemical Characterization of Thyroid Gland Angiomatoid Tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 22 publications
0
14
0
Order By: Relevance
“…Immunohistochemical confirmation of the diagnosis of angiosarcoma, even those that are poorly differentiated, can usually be obtained using a panel of vascular markers. Antibody directed against CD31 is still considered the most sensitive and specific marker for endothelial differentiation, being expressed in 90% of angiosarcomas and in slightly more than 1% of carcinomas; the endothelial marker CD34 and the antigen related to factor VIII should also be added to the panel [10,20]. …”
Section: Discussionmentioning
confidence: 99%
“…Immunohistochemical confirmation of the diagnosis of angiosarcoma, even those that are poorly differentiated, can usually be obtained using a panel of vascular markers. Antibody directed against CD31 is still considered the most sensitive and specific marker for endothelial differentiation, being expressed in 90% of angiosarcomas and in slightly more than 1% of carcinomas; the endothelial marker CD34 and the antigen related to factor VIII should also be added to the panel [10,20]. …”
Section: Discussionmentioning
confidence: 99%
“…These immunohistochemical results well corresponded to the sensitive marker of Ulex europaeus 1 lectin and specific marker of factor VIIIrelated antigen (12,13). However, considering immunohistochemical heterogeneity of angiosarcomatoid neoplasm of the thyroid, these immunohistochemical findings simply document the phenotype of the tumor, and does not equate with the definition of the cellular origin (9,14,15). In our opinion, it is more reasonable that the mass should be diagnosed as angiosarcoma admixed with well differentiated follicular carcinoma rather than anaplastic carcinoma or sarcomatoid carcinoma with angiosarcomatous differentiation, because there was neither histological anaplasia in follicular carcinoma portion nor cytokeratin-reactivity in angiosarcoma portion.…”
Section: A B C Dmentioning
confidence: 99%
“…One case in which angiosarcoma was thought to be a metastasis in the thyroid was excluded [5]. Follow-up data were available in 46 cases [2,3,4,5,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,27,31,33,34]. Seven cases were unsuccessfully followed-up [2,3,19,28,29], one died of unrelated causes [2], and the remaining four cases had incomplete data.…”
Section: Literature Reviewmentioning
confidence: 99%